ARTIVION, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 23.4 USD | -1.39% |
|
0.00% | +30.87% |
| May. 07 | Stifel Adjusts Price Target on Artivion to $25 From $22, Maintains Buy Rating | MT |
| May. 07 | Needham Adjusts Price Target on Artivion to $30 From $25, Maintains Buy Rating | MT |
Presenter SpeechSeth Damergy (Analysts)Thank you, everyone, for joining us for this session. I...
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe
Artivion, Inc. is a medical device company engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease, heart valve disease, aortic aneurysms, and dissections. The Company's segments include Medical Devices and Preservation Services. The Medical Devices segment includes sales of aortic stent grafts, surgical sealants, and On-X. The Preservation Services segment includes services for the preservation of cardiac and vascular implantable human tissues. It has four product families: aortic stent grafts, surgical sealants, On-X mechanical heart valves and related surgical products, and implantable cardiac and vascular human tissues. Aortic stent grafts include aortic arch stent grafts, abdominal stent grafts, and synthetic vascular grafts. Surgical sealants include BioGlue Surgical Adhesive products. It also sells or distributes PhotoFix bovine surgical patches.
Calendar
2024-07-31
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
23.73
USD
Average target price
26.75
USD
Spread / Average Target
+12.73%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +30.87% | 990M | |
| -4.56% | 182B | |
| +3.35% | 112B | |
| -2.42% | 68.58B | |
| +5.58% | 51.58B | |
| +7.78% | 44.24B | |
| +9.45% | 43.65B | |
| +26.09% | 32.46B | |
| +20.94% | 25.99B | |
| -0.31% | 25.61B |
- Stock Market
- Equities
- AORT Stock
- News Artivion, Inc.
- Transcript : Artivion, Inc. Presents at UBS Global Healthcare Conference, May-23-2022 02